Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCS-01 in Diabetic Macular Edema
NCT05343156Phase 2Completed
- Sponsor
- Oculis
- Start
- Sep 2017
- Primary completion
- Mar 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in diabetic macular edema (DME), sponsored by Oculis. Started Sep 2017; status: completed.
02
Drugs
dexamethasone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT05343156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05343156.